# Removal of volatile organic compounds by chemical filters significantly inhibited the development of atopic dermatitis symptoms in mice: potential implications for air-conditioning systems in healthcare environments

**Authors:** Chiharu Ohira, Kengo Tomita, Yukiko Ota, Keiichi Yano, Mona Amano, Mao Kaneki, Atsushi Yamada, Riku Usui, Yuzo Nagai, Masaki Nagane, Satoshi Takagi, Tomoki Fukuyama

PMC · DOI: 10.1093/toxsci/kfag009 · Toxicological Sciences · 2026-02-12

## TL;DR

Removing volatile organic compounds (VOCs) in healthcare environments may help prevent or reduce atopic dermatitis symptoms in mice.

## Contribution

This study demonstrates that VOC removal using chemical filters can inhibit AD development in a mouse model and in real clinical settings.

## Key findings

- VOC exposure worsened AD symptoms and keratinocyte inflammation in mice.
- Chemical filters effectively reduced VOC levels and suppressed AD development.
- VOC removal had limited effects on systemic immunological markers.

## Abstract

Volatile organic compounds (VOCs) are increasingly implicated in systemic diseases, but their contribution to skin disorders such as atopic dermatitis (AD) remains unclear. This study assessed VOC concentrations in medical environments, their effects on AD development, and the efficacy of VOC removal using chemical filters. Total VOC levels were monitored in 3 types of veterinary hospitals. AD-like lesions were induced in female NC/Nga mice by repeated dermal application of toluene diisocyanate or house dust mite ointment, with or without topical exposure to a VOC mixture (10 μg/ml). Clinical parameters, including dermatitis scores, transepidermal water loss, and skin thickness, were measured weekly, and immunological and histological analyses were performed. VOC monitoring revealed that 1 hospital exhibited concentrations exceeding 400 μg/m³. In the mouse model, direct VOC exposure significantly aggravated keratinocyte inflammation and worsened AD symptoms. Application of chemical filtering systems effectively reduced VOC levels in real clinical settings, and their use in the experimental model suppressed AD development. However, therapeutic application of VOC removal showed only limited effects on systemic immunological markers. These findings suggest that VOCs present in healthcare environments may contribute to the onset and progression of AD. Incorporating VOC-removing filters into air-conditioning systems could serve as a preventive strategy to improve the management of allergic skin diseases.

## Linked entities

- **Chemicals:** toluene diisocyanate (PubChem CID 21584847)
- **Diseases:** atopic dermatitis (MONDO:0004980)

## Full-text entities

- **Diseases:** inflammation (MESH:D007249), allergic skin diseases (MESH:D012871), water loss (MESH:D000069578), AD (MESH:D003876), dermatitis (MESH:D003872)
- **Chemicals:** VOC (MESH:D055549), tolylene diisocyanate (MESH:D014051)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017123/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017123/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017123/full.md

---
Source: https://tomesphere.com/paper/PMC13017123